Stephen Congly

University of Calgary

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

Mang Ma

Professor

CANADA

View details

Sarah Haylock-Jacobs

Head of Clinical Operations

BugBiome

AUSTRALIA

View details

Hin Hin Ko

The University of British Columbia

CANADA

View details

Samuel S. Lee

University of Calgary Cumming School of Medicine

CANADA

View details

Karen Doucette

Professor

University of Alberta

CANADA

View details

Carla S. Coffin

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephen Congly

Research Interests

Explore related searches

Contact this professor

Articles (20)

A shared care program for the management of patients with chronic hepatitis B in a Canadian primary care refugee clinic

Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B

Hepatitis E virus seroprevalence is increased amongst pancreatic insufficient adults with cystic fibrosis – A single centre study

Reply to Suoh et al

Trends in Medicare versus Medicaid spending on CFTR modulator therapy – an economic evaluation

A global comparison of hepatitis B & C drug pricing

Phosphatidylethanol Is Cost-effective to Accurately Detect Periodic Alcohol Use in Patients With Alcohol-associated Liver Disease

Tumor Seeding With Needle Biopsy of Hepatocellular Carcinoma: A Systematic Review

Dedicated Automatic Recall Hepatocellular Cancer Surveillance Programme Demonstrates High Retention: A Population‐Based Cohort Study

Regulatory delays in approval of CFTR modulating agents in Canada

A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C

Medicare Part D Spending for Hepatitis B Virus Drugs: Completing the Picture and Extending the Dataset

Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving

Editorial: Alcohol‐related liver disease is the primary driver of cirrhosis‐related hospital admissions in the COVID‐19 era—What can be done?

Causes and Outcomes of Medicolegal Proceedings Following Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound in the United States

Causes and Outcomes of Medicolegal Proceedings Following Gastrointestinal Endoscopy in Canada

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review

An Incidental Finding of Spontaneous Hepatic Artery Thrombosis in a Healthy Patient

Extramedullary Myeloma to the Liver Following Bispecific Antigen T-Cell Treatment for Refractory Multiple Myeloma

Collaborators (6)

Mang Ma

Sarah Haylock-Jacobs

Hin Hin Ko

Samuel S. Lee

Karen Doucette

Carla S. Coffin

Make your next move.